Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Protocol for Teleneurology Assessment Program for Creutzfeldt-Jakob Disease (TAPCJD)

NCT07840547 is registered in ClinicalTrials.gov with University Hospitals Cleveland Medical Center as lead sponsor.

NCT NCT07840547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07840547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Protocol for Teleneurology Assessment Program for Creutzfeldt-Jakob Disease (TAPCJD)
Lead sponsor
University Hospitals Cleveland Medical Center
Phase
Observational
Overall status
Recruiting
Start date
January 25, 2022
Completion date
January 25, 2032
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

creutzfeldt-jakob disease (cjd) | prion disease